Table 1 Patient characteristics
From: Cancer related maternal mortality and delay in diagnosis and treatment: a case series on 26 cases
Patient | Tumour | Parity | GA a.d. (wks) | Stage/grade a.d. (TNM/FIGO) | Survival after diagnosis (days) | One-year survival in general (%) | Patient/doctor delay in diagnosis | Patient/doctor delay in treatment | Obstetrical outcome |
|---|---|---|---|---|---|---|---|---|---|
1 | Adrenal carcinoma | G5P3 | Pp | IV | 133 | Unknown | Inconclusive | No | GA 36Â weeks; induction for suspicion of HELLP syndrome, but were metastasis. |
2 | Astrocytoma | G1P0 | Pp | II | 92 | 84 | Yes, both | Yes, doctor | GA 38Â weeks; induction for HELLP syndrome |
3 | Breast cancer | G2P1 | Pp | IV | 9 | 72 | Yes, doctor | No | GA 37Â weeks; SVD |
4 | Breast cancer | G9P6 | 12 | IV | 310 | 72 | NA | No | GA 32Â weeks; emergency CS when patient was found in coma. |
5 | Breast cancer | G3P2 | Pp | IV | 126 | 72 | Yes, patient | Yes, patient | GA 39Â weeks; induction for excessive skeletal pains |
6 | Cervical carcinoma | G2P1 | 25 | IV | 352 | 44–54 | No | No | GA 34 weeks; maternal deterioration |
7 | Cholangio- carcinoma | G3P0 | 28 | IV | 81 | 13 | Yes, doctor | No | GA 28Â weeks; CS for fetal distress |
8 | Esophagus carcinoma | G5P4 | 28 | IV | 78 | 20 | No | No | GA 36Â weeks; induction for therapy planning |
9 | Esophagus carcinoma | G1P0 | 17 | Unknown | 110 | 29 | NA | Yes, doctor | IUFD at GA 22Â weeks |
10 | Gastric carcinoma | G3P1 | 23 | IV | 78 | 17 | No | No | GA 29Â weeks; CS for maternal deterioration and breech position |
11 | Gastric carcinoma | G2P1 | 18 | IV | 171 | 17 | Yes, doctor | No | GA 18Â weeks; immature delivery after surgery. |
12 | Glioblastoma multiforme | G14P10 | 16 | IV | 87 | 38 | No | No | IUFD at GA 27Â weeks |
13 | Glioblastoma multiforme | G2P1 | 28 | IV | 270 | 38 | Yes, doctor | Yes, patient | GA 34Â weeks; CS for twin and maternal deterioration |
14 | Glioblastoma multiforme | G4P3 | 16 | IV | 15 | 38 | Yes, doctor | No | Died while pregnant (GA 18Â weeks) |
15 | Lung carcinoma | G2P1 | 36 | IV | 149 | 22 | Yes, both | NA | GA 36Â weeks; induction for therapy planning |
16 | Melanoma | G1P0 | 26 | IV | 15 | 32 | No | NA | Died while pregnant (GA 29Â weeks) |
17 | Melanoma | G2P1 | 21 | IIIC | 154 | 82 | No | Yes, doctor | Term; SVD |
18 | Melanoma | G4P2 | Pp | IV | 47 | 32 | Yes, doctor | No | GA 40Â weeks; SVD |
19 | Melanoma | G1P0 | 16 | IV | 167 | 32 | No | Yes, patient | GA 32Â weeks; fetal distress |
20 | Non-Hodgkin lymphoma | G3P2 | Pp | IVB | 20 | 67 | Yes, doctor | No | Term; SVD |
21 | Ovarian carcinoma | G2P1 | 34 | IIIB | 176 | 77 | Yes, patient | No | GA 35Â weeks; induction for therapy planning |
22 | Pancreatic carcinoma | G1P0 | 24 | IV | 37 | 10 | No | No | GA 28Â weeks; SVD |
23 | Pilocytic astrocytoma | G2P1 | 17 | I | 3 | 89 | No | No | Died during pregnancy (GA 17Â weeks) |
24 | Rectum carcinoma | G2P1 | 37 | IV | 134 | 46–70 | Yes, doctor | No | GA 37 weeks; induction after diagnosis. |
25 | Satellite tumour CNS | G1P0 | 21 | III | 130 | 61 | No | Yes, doctor | GA 34Â weeks; CS for maternal deterioration |
26 | Unknown primary tumour | G1P0 | Pp | IV | 82 | – | Yes, NA | No | GA 26 weeks; CS for HELLP. Neonatal death after 4 days. |